SELLAS Life Sciences Group, Inc.

Ownership Transactions Reported by 10 Insiders

Symbol
SLS on Nasdaq
Location
7 Times Square, Suite 2503, New York, NY

There are no Buy or Sell transactions made by insiders since 10/5/2023

SELLAS Life Sciences Group, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Angelos M. Stergiou President and CEO, Director $2.59M Jan 22, 2024
Barbara A. Wood EVP, Gen. Counsel, Corp. Sec. $822K Jan 22, 2024
Dragan Cicic SVP, Chief Development Officer $741K Jun 20, 2024
John Burns Cfo $696K Jan 22, 2024
Robert Francomano Chief Commercial Officer $278K Jan 22, 2024
David A. Scheinberg Director $66.1K Jan 22, 2024
John Varian Director $65K Jan 22, 2024
Robert L. Van Nostrand Director $65K Jan 22, 2024
Jane Wasman Director $65K Jan 22, 2024
Katherine Bach Kalin Director $53.1K Jan 22, 2024

Recent Insider Transactions by Companies or Individuals for SELLAS Life Sciences Group, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.